Key Points
- CEO Virgilio Deloy Capobian Gibbon sold approximately 26,520 shares of Afya between March 25 and April 1 across four transactions, totaling about $398,094.
- Afya announced an annual dividend of $0.656, payable April 6 to shareholders of record March 25, with a reported dividend payout ratio of 45.21%.
- Quarterly results and analyst view: Afya beat EPS expectations ($0.41 vs. $0.36) but missed revenue estimates ($147.1M vs. $174.7M); the stock carries a consensus "Hold" rating with a $17.30 price target.
Afya Limited (NASDAQ:AFYA - Get Free Report) CEO Virgilio Deloy Capobian Gibbon sold 2,320 shares of Afya stock in a transaction dated Tuesday, March 31st. The stock was sold at an average price of $14.92, for a total value of $34,614.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
Virgilio Deloy Capobian Gibbon also recently made the following trade(s):
- On Wednesday, April 1st, Virgilio Deloy Capobian Gibbon sold 19,500 shares of Afya stock. The stock was sold at an average price of $14.98, for a total value of $292,110.00.
- On Thursday, March 26th, Virgilio Deloy Capobian Gibbon sold 800 shares of Afya stock. The shares were sold at an average price of $15.21, for a total value of $12,168.00.
- On Wednesday, March 25th, Virgilio Deloy Capobian Gibbon sold 3,900 shares of Afya stock. The shares were sold at an average price of $15.18, for a total value of $59,202.00.
Afya Price Performance
Shares of Afya stock opened at $14.96 on Friday. The stock has a market cap of $1.40 billion, a price-to-earnings ratio of 10.25, a price-to-earnings-growth ratio of 0.67 and a beta of 0.48. The company has a debt-to-equity ratio of 0.21, a quick ratio of 0.98 and a current ratio of 2.20. The stock has a 50 day moving average price of $14.46 and a 200-day moving average price of $14.73. Afya Limited has a one year low of $13.00 and a one year high of $19.90.
Afya (NASDAQ:AFYA - Get Free Report) last released its quarterly earnings results on Wednesday, March 11th. The company reported $0.41 earnings per share for the quarter, beating the consensus estimate of $0.36 by $0.05. The company had revenue of $147.08 million for the quarter, compared to analyst estimates of $174.74 million. Afya had a return on equity of 18.77% and a net margin of 20.31%. Equities analysts expect that Afya Limited will post 1.52 EPS for the current year.
Afya Dividend Announcement
The company also recently announced an annual dividend, which will be paid on Monday, April 6th. Stockholders of record on Wednesday, March 25th will be issued a $0.656 dividend. This represents a dividend yield of 433.0%. The ex-dividend date is Wednesday, March 25th. Afya's dividend payout ratio (DPR) is 45.21%.
Wall Street Analyst Weigh In
Several brokerages recently commented on AFYA. Zacks Research upgraded shares of Afya from a "strong sell" rating to a "hold" rating in a report on Monday, March 9th. JPMorgan Chase & Co. restated a "neutral" rating and set a $22.00 target price (down from $24.50) on shares of Afya in a research report on Wednesday, January 7th. Sanford C. Bernstein raised Afya to a "market perform" rating in a research note on Friday, January 16th. Bank of America downgraded Afya from a "buy" rating to a "neutral" rating and reduced their price target for the stock from $22.00 to $17.00 in a report on Tuesday, February 24th. Finally, Weiss Ratings reissued a "hold (c)" rating on shares of Afya in a research note on Wednesday, January 21st. One investment analyst has rated the stock with a Buy rating and seven have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus price target of $17.30.
Read Our Latest Report on AFYA
Institutional Trading of Afya
Several institutional investors and hedge funds have recently modified their holdings of AFYA. XTX Topco Ltd bought a new position in Afya in the fourth quarter worth approximately $215,000. Mangrove Partners IM LLC bought a new stake in Afya during the 4th quarter valued at $197,000. State Street Corp lifted its holdings in shares of Afya by 25.8% in the 4th quarter. State Street Corp now owns 126,914 shares of the company's stock worth $1,955,000 after buying an additional 26,005 shares during the period. Campbell & CO Investment Adviser LLC grew its position in shares of Afya by 45.3% during the 4th quarter. Campbell & CO Investment Adviser LLC now owns 39,683 shares of the company's stock worth $612,000 after buying an additional 12,365 shares in the last quarter. Finally, Banco BTG Pactual S.A. bought a new position in shares of Afya during the 4th quarter worth $462,000. Institutional investors own 88.02% of the company's stock.
About Afya
(
Get Free Report)
Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.
At the core of Afya's offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
